ABC | Volume 115, Nº2, August 2020

Original Article Cadore et al. Preventive Angioplasty in Myocardial Infarction Arq Bras Cardiol. 2020; 115(2):229-237 18. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, et al. Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS- AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2011;58(7):704-11. 19. Santos AR, Piçarra BC, Celeiro M, Bento A, Aguiar J. Multivessel approach in ST-elevation myocardial infarction: impact on in-hospital morbidity and mortality. Rev Port Cardiol. 2014;33(2):67-73. 20. De Luca G, Navarese E, Marino P. Risk profile and benefits fromGp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treatedwith primary angioplasty: ameta-regression analysis of randomized trials. Eur Heart J. 2009;30(22):2705-13. 21. Califf RM, Pryor DB, Greenfield JC. Beyond randomized trials: applying clinical experience in the treatment of patients with coronary artery disease. Circulation. 1986;74(6):1191-94. 22. JensenLO,ThayssenP,FarkasDK,HougaardM,TekelsenCJ,TilstedHH,etal. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. EuroIntervention. 2012;8(4):456-64. 23. Hambraeus K, Jensevik K, Lagerqvist B, Lindahl B, Carlsson R, Farzaneh- Far R, et al. Long-Term Outcome of Incomplete Revascularization After Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry. JACC Cardiovasc Interv. 2016;9(3):207-15. 24. Cuisset T, Noc M. Multivessel PCI in STEMI: ready to be the recommended strategy? EuroIntervention. 2014;10(Suppl T):T47-54. 236